dalteparin has been researched along with Cystic Fibrosis of Pancreas in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gersch, K | 1 |
| Spencer, TR | 1 |
| Elidemir, O | 1 |
| Smith, KJ | 1 |
| Schecter, MG | 1 |
| Seethamraju, H | 1 |
| Mahoney, DH | 1 |
| McKenzie, ED | 1 |
| Mallory, GB | 1 |
3 other studies available for dalteparin and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
New-onset seizure activity in a transplant patient on immunosuppressive therapy.
Topics: Cystic Fibrosis; Emergency Service, Hospital; Enoxaparin; Epilepsy; Female; Hemorrhage; Humans; Hype | 2020 |
New-onset seizure activity in a transplant patient on immunosuppressive therapy.
Topics: Cystic Fibrosis; Emergency Service, Hospital; Enoxaparin; Epilepsy; Female; Hemorrhage; Humans; Hype | 2020 |
Lung transplantation in a patient with a thrombophilic disorder.
Topics: Adult; Cystic Fibrosis; Enoxaparin; Fatal Outcome; Female; Heparin; Heterozygote; Humans; Hypertensi | 2008 |